Bone Matrix Graft Products Linked to Tuberculosis Risks, FDA Warns
The FDA is calling for more stringent screening of bone matrix tissue donors in light of repeated tuberculosis outbreaks among bone graft patients
The FDA is calling for more stringent screening of bone matrix tissue donors in light of repeated tuberculosis outbreaks among bone graft patients
Prior warnings and recalls of the limb-lengthening implants have raised concerns about biocompatibility problems, leading the FDA to warn doctors to remove the devices after one year.